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Abstract
Introduction: Culture-negative sepsis is a common but relatively understudied condition. The aim of this study
was to compare the characteristics and outcomes of culture-negative versus culture-positive severe sepsis.
Methods: This was a prospective observational cohort study of 1001 patients who were admitted to the medical
intensive care unit (ICU) of a university hospital from 2004 to 2009 with severe sepsis. Patients with documented
fungal, viral, and parasitic infections were excluded.
Results: There were 415 culture-negative patients (41.5%) and 586 culture-positive patients (58.5%). Gram-positive
bacteria were isolated in 257 patients, and gram-negative bacteria in 390 patients. Culture-negative patients were more
often women and had fewer comorbidities, less tachycardia, higher blood pressure, lower procalcitonin levels, lower
Acute Physiology and Chronic Health Evaluation II (median 25.0 (interquartile range 19.0 to 32.0) versus 27.0 (21.0 to
33.0), P = 0.001) and Sequential Organ Failure Assessment scores, less cardiovascular, central nervous system, and
coagulation failures, and less need for vasoactive agents than culture-positive patients. The lungs were a more common
site of infection, while urinary tract, soft tissue and skin infections, infective endocarditis and primary bacteremia were
less common in culture-negative than in culture-positive patients. Culture-negative patients had a shorter duration of
hospital stay (12 days (7.0 to 21.0) versus 15.0 (7.0 to27.0), P = 0.02) and lower ICU mortality than culture-positive
patients. Hospital mortality was lower in the culture-negative group (35.9%) than in the culture-positive group (44.0%,
P = 0.01), the culture-positive subgroup, which received early appropriate antibiotics (41.9%, P = 0.11), and the
culture-positive subgroup, which did not (55.5%, P < 0.001). After adjusting for covariates, culture positivity was not
independently associated with mortality on multivariable analysis.
Conclusions: Significant differences between culture-negative and culture-positive sepsis are identified, with the
former group having fewer comorbidities, milder severity of illness, shorter hospitalizations, and lower mortality.
Introduction
Severe sepsis is a major cause of morbidity and mortality
in both developed and developing countries [1]. Mortality
rates remain high at 30% and rise to 60% in the presence
of septic shock despite significant advancement in treat-
ment modalities [2]. Bacteria are by far the most com-
mon causative microorganisms in sepsis, and cultures are
positive in about 50% of cases [3]. Failure to administer
antibiotics to which the pathogens are susceptible is
associated with increased mortality [4]. Thus, early
broad-spectrum antibacterial agents are recommended as
a means to improve survival [5].
Less is known though about the other half of the equa-
tion: sepsis for which etiologic agents are not found. It is
commonly thought that cultures may lack the sensitivity
to detect all infecting bacteria [6]. Beyond this, and aside
from data from a few multicenter epidemiological studies,
which suggest that severity of illness and mortality are not
significantly affected by microbiological documentation in
sepsis [7-12], the medical literature is surprisingly devoid
of information about patients with culture-negative sepsis.
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The aim of our study was hence to compare the charac-




This was a prospective observational cohort study con-
ducted in the medical intensive care unit (ICU) of our
university hospital. The study, being non-interventional,
was approved by our institutional review board, the
National Healthcare Group’s Domain Specific Review
Board, with a waiver of informed consent.
Inclusion criteria
We included all patients who were admitted to our ICU
from 2004 to 2009 for severe sepsis, which was defined
according to the 1992 American College of Chest Physi-
cians (ACCP)/Society of Critical Care Medicine (SCCM)
Consensus Conference criteria, that is, sepsis with at least
one organ dysfunction [13]. The diagnosis of sepsis
required the presence of the systemic inflammatory
response syndrome due to infection.
Exclusion criteria
As we were interested in comparing acute culture-negative
sepsis with culture-positive bacterial sepsis, we excluded
patients with microbiogically proven fungal, viral, and
parasitic infections, and tuberculosis. We only recorded
the first ICU admission and excluded readmissions.
Diagnosis of infection
Infection was diagnosed clinically by the managing phy-
sicians. From the year 2005 onward, reference was made
to the International Sepsis Forum Consensus Conference
guidelines on definitions of infections where appropriate
[14]. Briefly, the diagnosis of pneumonia required a
radiographic infiltrate plus a high clinical suspicion,
including fever or hypothermia, leukocytosis or leuko-
penia, and purulent respiratory secretions. Patients were
deemed culture-positive if etiologic agents were recov-
ered from blood or pleural fluid, or if semi-quantitative
cultures of sputum, blind endotracheal aspirates, or
bronchoalveolar lavage found moderate to heavy growths
of bacteria with few epithelial cells seen on Gram stain
examination (≤10 per high power field). Intra-abdominal
infections included but were not limited to intra-
abdominal abscesses, peritonitis, biliary tract infections,
pancreatic infections, enteritis, and colitis. Urinary tract
infection was diagnosed through typical signs and symp-
toms including fever, urgency, frequency, dysuria, pyuria,
hematuria, positive Gram stain, pus, and suggestive
imaging. Urine cultures were deemed positive with
the isolation of >105 colony forming units (cfu)/mL of
microorganisms (or 103 cfu/mL in catheterized patients).
Soft tissue and skin infections included surgical site
infections, cellulitis, and necrotizing fasciitis. Infective
endocarditis was diagnosed based on the revised Duke
criteria. When diagnosing bacteremia, common skin con-
taminants like coagulase-negative staphylococci, Bacillus
species, Corynebacterium species, micrococci, and
Propionibacterium species were disregarded unless they
were deemed clinically significant by the managing phy-
sicians or cultured from two or more blood cultures.
Primary bacteremia was diagnosed when the microor-
ganism cultured was not related to an infection at
another site. Catheter-related sepsis is the only infection
for which microbiological confirmation was mandated
by the International Sepsis Forum [14]. For this study,
the diagnosis of culture-positive catheter-related sepsis
required a positive peripheral blood culture, while the
diagnosis of culture-negative catheter-related sepsis was
made clinically in the presence of pus or cellulitis at the
exit site or tunnel tract infection.
Clinical management
Patient care in the ICU was left to the discretion of the
managing physicians, who were encouraged to follow
the Surviving Sepsis Campaign guidelines after they
were published in 2004 [15]. While the treatments were
not protocolized, broadly, they involved aggressive fluid
resuscitation and vasopressors, with hemodynamic infor-
mation obtained via lactate and N-terminal B-type
natriuretic peptide measurements, transthoracic echo-
cardiography, arterial pressure waveform analyses, and
transpulmonary thermodilution when indicated. Early
intubation was advocated for respiratory failure. Blood
cultures were obtained early, with 20 mL of blood distri-
buted equally for each set of aerobic and anaerobic
media, while cultures of other sites were performed
depending on the source of infection. Empiric broad
spectrum antibiotics were chosen based on the suspected
infection and optimized and/or de-escalated according to
the culture results.
Data collection
A research coordinator (WJN) prospectively entered the
data into a Computerized Clinical Research Database
under the close supervision of the principal investigator
(JP). Patients were followed till discharge from or death in
the hospital. The inputted data and electronic case records
for all patients were then retrospectively reviewed by the
co-investigators. Data including statistical outliers that
might represent entry errors were verified and corrected
in cases of inconsistency.
Data collected were baseline variables on entry to the
ICU including patient demographics, source and time of
admission, comorbidities, vital signs and blood investi-
gations (white blood cell count, procalcitonin, and
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C-reactive protein where available), and variables on the
first day of ICU admission including the Acute Physiology
and Chronic Health Evaluation (APACHE) II and the cor-
responding Acute Physiology Score, the Sequential Organ
Failure Assessment (SOFA) score, and treatment provided
(vasoactive agents, mechanical ventilation, renal replace-
ment therapy, and glucocorticoids for septic shock). We
defined organ failures as a SOFA score of >2 for the
organs concerned [11]. We documented the site(s) of
infection based on the clinical impression of the managing
physicians. To ensure that any bacteria isolated were the
cause of severe sepsis that resulted in ICU admission, we
recorded results of all bacteria cultures collected within
the two days before and the two days after admission,
unless they were deemed to be colonizers or contaminants
by the managing physicians; in the latter cases, adjudi-
cation was provided by the principal investigator (JP).
Bacteria isolated more than two days before ICU admi-
ssion were only logged if they were judged to have led to
the clinical deterioration by the managing physicians. We
charted all antibiotics administered on the day of ICU
admission and defined the initial antimicrobial therapy as
appropriate if positive cultures were susceptible to any of
these antibiotics or if all cultures were negative, and as
inappropriate if positive cultures were not susceptible to
all of these antibiotics [4].
The primary outcome variable was hospital mortality,
while the secondary outcome variables were ICU mor-
tality, duration of mechanical ventilation, ICU stay, and
hospital stay.
Statistical analyses
We classified the patients into two groups depending on
whether bacteria which caused the severe sepsis were
found (culture-positive) or not found (culture-negative).
We expressed categorical variables as number (percentage).
After using the Kolmogorov-Smirnov test and examining
histograms to verify if normality and homogeneity assump-
tions were satisfied, we expressed normally distributed
numerical variables as mean (95% confidence interval (CI))
and other numerical variables as median (interquartile
range). We compared categorical variables using the c2
test or Fisher exact test, normally distributed quantitative
variables with the t test, and other quantitative variables
with the Mann-Whitney U test. We used the Bonferroni
correction for pairwise comparisons.
To identify the independent predictors of hospital
mortality, in addition to univariable analyses, we per-
formed a multivariable logistic regression analysis using a
model that included variables which could potentially
affect survival, that is, all recorded variables at baseline
and on day one in the ICU, the site of infection, whether
the patients were culture-negative or culture-positive,
whether the initial antimicrobial therapy was appropriate
or inappropriate, and whether bacteremia was absent or
present. We looked for multicollinearity, and assessed
model fit using the Hosmer-Lemeshow goodness-of-fit
test. To identify the specific bacteria that were indepen-
dently associated with mortality, we repeated the regres-
sion analysis after substituting the five commonest
Gram-negative microorganisms and the five commonest
Gram-positive microorganisms for the broad groups of
culture negativity versus culture positivity as covariates
into the model. We considered a P value of < 0.05 signifi-
cant and used IBM SPSS version 20.0 (IBM Corp,
Armonk, NY, USA).
Results
The study included 415 culture-negative patients (41.5%)
and 586 culture-positive patients (58.5%) who were
admitted to our ICU for severe sepsis. Table 1 describes
their characteristics at baseline and on day one of the
ICU stay. Compared to culture-positive patients, culture-
negative patients were more likely to be women, have
fewer comorbid conditions, less tachycardia, higher blood
pressure, lower procalcitonin levels, lower APACHE
II and SOFA scores, and less cardiovascular, central
nervous system, and coagulation failures. Culture-negative
patients were less likely to be treated with vasoactive
agents on the first day of ICU stay.
As shown in Table 2, the lungs were commoner sites
of infection, while liver abscesses, biliary tract, urinary
tract, soft tissue and skin infections, infective endocardi-
tis and primary bacteremia were less common in cul-
ture-negative than in culture-positive patients.
Table 3 lists the cultures performed within the two
days before and the two days after ICU admission and
the culture positivity rates. While more cultures were
obtained from bile, liver abscesses, and soft tissue and
skin in the culture-positive group than in the culture-
negative group, there were no significant differences in
the proportion of patients for which other cultures were
performed in the two groups. Blood, urine, and endotra-
cheal aspirate cultures were most frequently performed.
A median of two blood cultures, one urine culture, and
one endotracheal aspirate culture were obtained for both
the culture-negative and the culture-positive patients.
Table 4 features the microbiology. Gram-positive bac-
teria were isolated in 257 patients (25.7%) while Gram-
negative bacteria were isolated in 390 patients (39.0%).
Among these patients, 196 (19.6%) had only Gram-positive
infections, 329 (32.9%) only Gram-negative infections,
while 61 (6.1%) had mixed Gram-positive and Gram-
negative infections. Staphylococcus aureus and Klebsiella
pneumonia were the commonest Gram-positive and
Gram-negative microorganisms respectively.
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Table 1 Characteristics at baseline and on day one of intensive care unit admission.
Culture-negative patients (n = 415) Culture-positive patients (n = 586) P value
Demographics
Age, years 62.0 (50.0-74.0) 64.0 (50.1-74.0) 0.62
Men 236 (56.9) 375 (64.0) 0.02
Race 0.09
Chinese 229 (55.2) 358 (61.1)
Malay 106 (25.5) 120 (20.5)
Indian 56 (13.5) 64 (10.9)
Others 24 (5.8) 44 (7.5)
Source of admission 0.49
Emergency department 195 (47.0) 257 (43.9)
Hospital floor 195 (47.0) 293 (50.0)
Other ICU 25 (6.0) 34 (5.8)
Operating room/recovery 0 (0) 2 (0.3)
Time of ICU admission
Day of hospital admission 0 (0-2.00) 0 (0-2.00) 0.38
Office hour admission 166 (40.0) 260 (44.4) 0.17
Comorbid conditions
Diabetes mellitus 141 (34.0) 234 (39.9) 0.06
Chronic heart failure 22 (5.3) 40 (6.8) 0.32
Chronic kidney disease 48 (11.6) 96 (16.4) 0.03
COPD 24 (5.8) 38 (6.5) 0.65
Cancer 29 (7.0) 55 (9.4) 0.18
Hematological malignancy 9 (2.2) 24 (4.1) 0.09
No. of comorbid conditionsa 0.004
0 214 (51.6) 241 (41.1)
1 136 (32.8) 225 (38.4)
2 59 (14.2) 98 (16.7)
≥3 6 (1.4) 22 (3.8)
Vital signs upon ICU admission
Temperature, °C 37.0 (36.0-38.0) 37 (36.2-38.0) 0.29
Heart rate, /min 107.3 ± 27.5 113.4 ± 25.9 <0.001
Mean blood pressure, mm Hg 78.0 (64.0-96.0) 75.0 (62.0-91.0) 0.01
Respiratory rate, /min 24.0 (20.0-31.0) 25.0 (20.0-31.0) 0.84
Investigationsb
White blood cell, 109/L 13.27 (9.18-19.47) 13.44 (6.58-19.65) 0.19
Procalcitonin, ng/mL 3.95 (0.90-17.28) 16.40 (2.74-47.03) <0.001
C-reactive protein, mg/L 47.50 (14.05-191.50) 51.50 (11.63-181.50) 0.53
Severity scores
APACHE II 25.0 (19.0-32.0) 27.0 (21.0-33.0) 0.001
Acute Physiology Score 20.0 (14.0-26.0) 22.0 (16.8-28.3) <0.001
SOFA 9.0 (6.0-12.0) 10.0 (8.0-13.0) <0.001
Organ failurec
Renal 88 (21.2) 127 (21.7) 0.86
Respiratory 239 (57.6) 344 (58.7) 0.73
Cardiovascular 205 (49.4) 360 (61.4) <0.001
Central nervous system 142 (34.2) 241 (41.1) 0.03
Coagulation 31 (7.5) 66 (11.3) 0.046
Hepatic 15 (3.6) 37 (6.3) 0.06
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Table 2 Site of infection.
Site of infectiona Culture-negative patients (n = 415) Culture-positive patients (n = 586) P value
Lungs 309 (74.5) 351 (59.9) <0.001
Abdomen 41 (9.9) 78 (13.3) 0.10
Enteritis and colitis 22 (5.3) 18 (3.1) 0.08
Biliary 8 (1.9) 25 (4.3) 0.04
Peritonitis 6 (1.4) 13 (2.2) 0.38
Liver abscess 1 (0.2) 17 (2.9) 0.002
Other abscess (0.2) 4 (0.7) 0.41
Pancreatic 1 (0.2) 1 (0.2) 1.00
Other abdominal 2 (0.5) 0 (0) 0.17
Urinary tract 17 (4.1) 71 (12.1) <0.001
Soft tissue and skin 10 (2.4) 31 (5.3) 0.02
Nervous system 2 (0.5) 8 (1.4) 0.21
Bones and joints 2 (0.5) 8 (1.4) 0.21
Infective endocarditis 2 (0.5) 14 (2.4) 0.02
Primary bacteremia 0 (0) 12 (2.0) 0.002
Others 14 (3.4) 15 (2.6) 0.45
Unknown 18 (4.3) 29 (4.9) 0.65
aSome patients had more than one site of infection.
Table 3 Cultures performed.
Type of culturea Culture-negative patients (n = 415) Culture-positive patients (n = 586) P value Rate of culture positivity (%)b
Blood 410 (98.8) 579 (98.8) 1.00 20.3
Urine 310 (74.7) 445 (75.9) 0.65 11.0
Endotracheal aspirate 216 (52.0) 332 (56.7) 0.15 39.4
Expectorated sputum 101 (24.3) 146 (24.9) 0.84 34.8
Bronchoalveolar lavage 24 (5.8) 32 (5.5) 0.83 51.7
Pleural fluid 12 (2.9) 14 (2.4) 0.62 14.8
Stool 43 (10.4) 74 (12.6) 0.27 4.2
Peritoneal fluid 9 (2.2) 22 (3.8) 0.15 20.6
Bile 0 (0) 6 (1.0) 0.045 83.3
Liver abscess 0 (0) 7 (1.2) 0.046 85.7
Other abscess 1 (0.2) 3 (0.5) 0.65 60.0
Soft tissue and skin 9 (2.2) 36 (6.1) 0.003 65.5
Cerebrospinal fluid 8 (1.9) 8 (1.4) 0.48 12.5
Synovial fluid 1 (0.2) 5 (0.9) 0.41 88.9
Others 6 (1.4) 14 (2.4) 0.29 56.5
aCultures collected within two days before and the two days after ICU admission were included; bcalculated as (total number of positive cultures divided by total
number of cultures performed) × 100. ICU, intensive care unit.
Table 1 Characteristics at baseline and on day one of intensive care unit admission. (Continued)
Treatment on day one in the ICU
Vasoactive agents 247 (59.5) 432 (73.7) <0.001
Mechanical ventilation 315 (75.9) 469 (80.0) 0.12
Renal replacement therapy 37 (8.9) 51 (8.7) 0.91
Glucocorticoids for septic shock 104 (25.1) 143 (24.4) 0.81
aCulture-negative patients were more likely to have no comorbidities than culture-positive patients (P = 0.001, significant after Bonferroni correction); bwhite
blood cell values available for all patients; procalcitonin values available for 266 culture-negative and 359 culture-positive patients; C-reactive protein values
available for 120 culture-negative patients and 174 culture-positive patients; corgan failure defined as SOFA score >2 for the specified organ. ICU, intensive care
unit; COPD, chronic obstructive pulmonary disease; APACHE, Acute Physiology and Chronic Health Evaluation; SOFA, Sequential Organ Failure Assessment.
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Patient outcomes are presented in Table 5. Culture-
negative patients had a shorter duration of hospital stay,
and lower ICU mortality and hospital mortality (35.9%
versus 44.0%, P = 0.01) than culture-positive patients.
Table 6 details the variables associated with hospital
mortality. While culture positivity was associated with
higher mortality on univariable analysis, it did not feature
as an independent predictor of mortality after accounting
for other covariates on logistic regression analysis. The
same applies to the administration of inappropriate
antibiotics on the day of ICU admission. Multivariable
analysis revealed the following independent predictors
of mortality: age, time from hospitalization to ICU
admission, lung, bone and joint infections, infective
endocarditis, primary bacteremia, Acute Physiology Score,
coagulation and hepatic failures, and mechanical venti-
lation on the day of ICU admission. The logistic regression
model fitted well and there was no multicollinearity. In a
separate analysis including specific microorganisms,
Pseudomonas aeruginosa was the only pathogen which,
when isolated independently, increased mortality (odds
ratio (OR) 2.02, 95% CI 1.08 to 3.79, P = 0.03).
Among the culture-positive patients, 265 were non-
bacteremic while 321 were bacteremic. Hospital mortality
was similar in both subgroups. The nonbacteremic but
culture-positive subgroup had a higher mortality rate
than the culture-negative group but this was not statisti-
cally significant; the bacteremic subgroup had a signifi-
cantly higher mortality rate than the culture-negative
group (Figure 1). Again among culture-positive patients,
467 received appropriate antibiotics on the first day of
ICU stay while 119 did not. Hospital mortality was higher
in the latter subgroup. The culture-positive subgroup
that received appropriate antibiotics had a higher mortal-
ity rate than the culture-negative group but this was not
statistically significant; the culture-positive subgroup that
Table 4 Bacteria isolated.
Bacteria isolateda No. of patients (% of entire cohort of patients)
All cultures Bacteremia
Gram-positive 257 (25.7) 120 (12.0)
Methicillin-sensitive Staphylococcus aureus 82 (8.2) 39 (39.0)
Methicillin-resistant Staphylococcus aureus 59 (5.9) 10 (1.0)
Streptococcus pneumoniae 67 (6.7) 39 (3.9)
Other Streptococcus species 19 (1.9) 15 (1.5)
Enterococcus 28 (2.8) 16 (1.6)
Others 9 (0.9) 5 (0.5)
Gram-negative 390 (39.0) 213 (21.3)
Klebsiella pneumoniae 131 (13.1) 73 (7.3)
Escherichia coli 117 (11.7) 80 (8.0)
Pseudomonas aeruginosa 62 (6.2) 15 (1.5)
Acinetobacter baumannii 35 (3.5) 10 (1.0)
Bulkholderia pseudomallei 13 (1.3) 10 (1.0)
Enterobacter cloacae 10 (1.0) 4 (0.4)
Hemophilus influenzae 9 (0.9) 1 (0.1)
Salmonella species 7 (0.7) 3 (0.3)
Citrobacter species 6 (0.6) 3 (0.3)
Stenotrophomonas maltophilia 6 (0.6) 1 (0.1)
Proteus species 5 (0.5) 5 (0.5)
Bacteroides fragilis 5 (0.5) 2 (0.2)
Others 23 (2.3) 14 (1.4)
aMore than one species of bacteria isolated in some patients.
Table 5 Outcomes.
Culture-negative patients (n = 415) Culture-positive patients (n = 586) P value
Hospital mortality 149 (35.9) 258 (44.0) 0.01
ICU mortality 139 (33.5) 232 (39.6) 0.049
Duration of mechanical ventilation, daysa 3.0 (1.0-7.0) 4.0 (1.0-8.0) 0.35
Duration of ICU stay, days 4.0 (2.0-8.0) 4.0 (2.0-9.0) 0.46
Duration of hospital stay, days 12.0 (7.0-21.0) 15.0 (7.0-27.0) 0.02
aA total of 326 culture-negative patients and 448 culture-positive patients were mechanically ventilated during the ICU stay. ICU, intensive care unit.
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did not receive appropriate antibiotics had a significantly
higher mortality rate than the culture-negative group
(Figure 2).
Discussion
To the best of our knowledge, no previous study has
focused on the differences between culture-negative and
culture-positive severe sepsis. The main findings of this
study are that patients with culture-negative sepsis had
fewer comorbidities and lower severity of illness than
those with culture-positive sepsis. Although culture-
negative patients had a shorter hospitalization and lower
ICU mortality and hospital mortality than culture-positive
patients, culture positivity per se was not independently
associated with mortality on multivariable analysis.
Causative microorganisms were not found in 41.5% of
our patients. Multicenter studies published in the last
decade found that culture-negative patients accounted
for 28%, 35%, 38%, and 48% of all cases of severe sepsis
in North American, Spanish, French, and Canadian
ICUs, respectively [10,16-18]. The corresponding figure
was 40% in the pan-European Sepsis Occurrence in
Acutely Ill Patients (SOAP) study [11]. In the United
States, 49% of hospitalized patients with sepsis were
culture-negative [3]. Meanwhile, the Extended Preva-
lence of Infection in Intensive Care (EPIC) II study,
which reported prevalence - and not incidence - found
that 30% of all infections in ICUs worldwide were culture-
negative [19]. While we found more Gram-negative
pathogens, others have found a predominance of Gram-
positive microorganisms [3,11].
Despite the high prevalence of culture-negative sepsis,
studies which focus on the outcomes of such patients
are surprisingly limited. In the 1990s, Rangel-Frausto
Table 6 Predictors of hospital mortality by univariable and multivariable logistic regression analyses.
Variablea Univariable OR (95% CI) P value Multivariable adjusted OR (95% CI)b P value
Demographics
Age, per year 1.02 (1.02-1.03) <0.001 1.03 (1.02-1.04) <0.001
Source of admission
Hospital floor versus ED 1.90 (1.46-2.48) <0.001 1.34 (0.97-1.85) 0.80
Other ICU versus ED 1.38 (1.05-1.81) 0.02 1.24 (0.64-2.38) 0.53
Time of ICU admission
Per day from hospitalization 1.06 (1.03-1.09) <0.001 1.06 (1.03-1.09) <0.001
Comorbid conditions
Chronic kidney disease 1.51 (1.06-2.15) 0.02 1.29 (0.80-2.08) 0.29
Hematological malignancy 2.03 (1.01-4.09) 0.048 1.40 (0.55-3.57) 0.48
Site of infection
Lungs 0.98 (0.75-1.27) 0.85 2.04 (1.00-4.16) 0.049
Bones and joints 5.94 (1.25-28.09) 0.03 7.31 (1.05-50.77) 0.04
Infective endocarditis 1.90 (0.70-5.13) 0.21 5.43 (1.41-20.87) 0.01
Primary bacteremia 4.46 (1.20-16.56) 0.03 8.31 (1.55-44.49) 0.01
Microbiology and antimicrobials
Culture-positive 1.40 (1.08-1.82) 0.01 0.88 (0.59-1.31) 0.52
Inappropriate antibiotics 1.42 (1.17-1.71) <0.001 0.86 (0.52-1.42) 0.56
Severity scores
APS, per point 1.07 (1.05-1.09) 0.001 1.06 (1.03-1.09) <0.001
Organ failurec
Renal 1.36 (1.00-1.84) 0.049 0.99 (0.64-1.55) 0.98
Respiratory 1.31 (1.02-1.70) 0.04 0.98 (0.70-1.36) 0.90
Cardiovascular 1.71 (1.32-2.21) <0.001 0.91 (0.57-1.44) 0.68
Central nervous system 2.17 (1.67-2.82) <0.001 1.15 (0.80-1.65) 0.45
Coagulation 3.02 (1.95-4.68) <0.001 2.59 (1.51-4.46) 0.001
Hepatic 4.27 (2.28-7.98) <0.001 6.30 (2.98-13.30) <0.001
Treatment on day 1 in the ICU
Vasoactive agents 2.07 (1.56-2.76) <0.001 1.42 (0.88-2.30) 0.15
Mechanical ventilation 3.17 (2.23-4.52) <0.001 1.91 (1.21-3.02) 0.005
aOnly variables that were significantly associated with hospital mortality on univariable or multivariable analyses are shown; bHosmer-Lemeshow test for
goodness of fit for multivariable logistic regression model: c2 = 7.208, degrees of freedom = 8, P = 0.51; corgan failure defined as Sequential Organ Failure
Assessment (SOFA) score >2 for the specified organ. OR, odds ratio; CI, confidence interval; ED, emergency department; ICU, intensive care unit; APS, Acute
Physiology Score, used in place of the Acute Physiology and Chronic Health Evaluation (APACHE) II score.
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and colleagues found a mortality of 25% among 577
patients with severe sepsis and septic shock in a teaching
hospital and no difference in outcomes between culture-
negative and culture-positive patients [9]. Mortality was
also similar among 310 culture-negative and 742 culture-
positive patients with severe sepsis in a multicenter study
by Brun-Buisson and colleagues [8]. In the 2000s, a
North American study led by Kumar and colleagues
found similar mortality among 608 culture-negative and
1,546 culture-negative patients [10], while the pan-
European SOAP study found similar ICU mortality rates
(40% versus 39%) between 468 culture-negative and 454
culture-positive septic patients [11]. Our study, on the
other hand, found a significantly lower hospital mortality
rate for culture-negative than for culture-positive severe
sepsis (35.9% versus 44.0%). Although this difference was
greater for bacteremic patients than for culture-positive
but nonbacteremic patients, there was no significant
Figure 1 Hospital mortality for subgroups according to cultures and bacteremia. Overall P value for comparison between three subgroups
was 0.03. Listed P values refer to comparisons between two subgroups. aSignificant after Bonferroni correction.
Figure 2 Hospital mortality for subgroups according to cultures and receipt of appropriate antibiotics. Overall P value for comparison
between three subgroups was 0.005. Listed P values refer to comparisons between two subgroups. aSignificant after Bonferroni correction.
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difference in mortality between these latter two sub-
groups (43.0% versus 44.9%). The reasons why we found
a difference in mortality when the earlier studies did not
are not immediately clear. These studies were not primar-
ily designed for such a comparison and did not provide
details on the severity of illness in these two groups of
patients. In Rangel-Frausto et al.’s cohort, culture-negative
patients were less likely to have acute kidney injury and
shock, but in Brun-Buisson et al.’s cohort, culture-negative
patients had more hypotension [8,9]. In our study, culture-
negative patients were clearly less sick than their culture-
positive counterparts: they had fewer comorbidities, less
hemodynamic instability and organ failures, and lower
APACHE II scores. After adjustment for covariates includ-
ing severity of illness, identification of microorganisms was
not independently associated with mortality, a finding
similarly reported recently by the French OUTCOMEREA
database [12].
The question that then begs to be answered is: what
exactly is the cause of culture-negative sepsis? Is it merely
a milder form of sepsis compared to culture-positive sep-
sis? While our study cannot answer these questions, its
findings provide some insight into four possibilities. First,
it is known that cultures lack the sensitivity to identify
all bacteria. Postulated reasons include prior antibiotic
exposure, sampling error, insufficient volume for blood
cultures, poor transport conditions, and slow-growing or
fastidious bacteria [6]. Polymerase chain reaction (PCR)-
based molecular techniques may improve detection rates,
and many patients with clinical sepsis are indeed PCR-
positive but culture-negative [20-22]. In the PIRO system
for staging sepsis, the letter ‘I’ refers to the nature and
extent of the infection [23]. It may be hypothesized that
the lower severity of culture-negative sepsis in our study
was at least in part due a milder insult and lower bacterial
burden [24], and correspondingly, the inability to capture
the microorganisms on cultures. While it is possible that
antibiotic pretreatment might have contributed to negative
cultures, this is less likely for blood cultures that were
usually performed before antimicrobial therapy. In addi-
tion, although we did not differentiate community-
acquired from hospital-acquired infections, the short
median (interquartile range (IQR)) lag time from presen-
tation to the hospital to ICU admission of 0 days (0 to 2)
suggests that most patients had the former, where the inci-
dence of antibiotic pretreatment is likely to be lower. The
letter ‘P’ in the PIRO system refers to predisposition [23],
and given the trend toward more culture-positive sepsis
among diabetic patients in our cohort, it is conceivable
that diabetics are more prone to having large bacterial
loads [25].
Second, it is clear from our data that certain infections
are less common in culture-negative than in culture-
positive patients, and vice versa. This is in part due to
the nature of some infections, for example, liver
abscesses are less likely to be culture-negative [26], and
in part due to the diagnostic criteria for other infections,
for example, the importance of blood culture positivity
for primary bacteremia and in the revised Duke criteria
for infective endocarditis.
Third, some of our culture-negative patients might
have had nonbacterial sepsis. Fungi account for approxi-
mately 5% of cases of sepsis in ICUs and are generally
more readily detected than viruses and parasites [16,17].
Our study design mandated the exclusion of such
microorganisms. While we are confident that most
patients with fungal sepsis were diagnosed and thus
excluded, and that parasites are extremely rare in our
urban setting, it is plausible that undetected viruses con-
tributed to a significant proportion of culture-negative
sepsis. Using reverse-transcription PCR assays on
bronchoalveolar lavage fluid and nasopharyngeal swab
specimens, Choi and colleagues recently demonstrated
that severe pneumonia was due to viruses 36% of the
time [27]. It is not routine clinical practice in most ICUs,
including ours, to test for viruses in pneumonia, and the
lungs were a commoner site of infection in culture-
negative than in culture-positive patients in our study.
Meanwhile, serum procalcitonin levels, which are a mar-
ker of bacterial as opposed to viral infections, were lower
in our culture-negative group, again bringing up the
possibility that viruses played a role [28].
Importantly, a fourth conceivable explanation for our
culture-negative group is that some of the patients did
not actually have sepsis. The 1992 ACCP/SCCM Con-
sensus Conference criteria that we and many other inves-
tigators used to define sepsis [11,17,18] - as well as
subsequent adaptations - are based on a composite of
clinical and laboratory data and will inevitably include a
heterogeneous set of diagnoses, some of which are false
positives and unrelated to infections [13,14,23]. In a
study by Heffner and colleagues, 32% of culture-negative
patients who were initially identified as having severe
sepsis in the emergency department were subsequently
found to have noninfectious mimics while 16% had
illnesses of indeterminate etiology [29]. Among our cul-
ture-negative patients, 74.5% had a lung infection, com-
pared to 64% in the European SOAP cohort [11]. This
might have been due to the fact that ours is a medical
ICU, but one could also postulate that some of our
patients had mimickers of pneumonia such as heart
failure. However, because we used all available clinical
information from ICU admission till discharge or death
before labeling severe sepsis, including noninvasive and
invasive hemodynamic monitoring where indicated, it is
likely that the proportion of patients who did not actually
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have sepsis in our study was smaller than in Heffner and
colleagues’ cohort.
What are the implications of our study’s findings?
Early administration of broad-spectrum antibiotics is
recommended by the Surviving Sepsis Campaign guide-
lines in an effort to improve outcomes in sepsis, culture-
positive or culture-negative [5]. Kumar and colleagues
showed that every hour of delay in the administration of
effective antibiotics from the onset of septic shock
resulted in an increase in mortality [10]. This association
occurred even among culture- negative patients, for
which antimicrobial therapy was deemed appropriate if
they were consistent with national guidelines modified to
local flora for the clinical syndrome. In contrast, similar
to the majority of studies in the literature [4], our study
defined the administered antibiotics to be inappropriate
only if they did not match the in vitro susceptibility of
the identified pathogens, that is, only in culture-positive
patients. In so doing, we found the mortality rate to
be much higher among culture-positive patients who
were administered inappropriate antibiotics than culture-
negative patients (55.5% versus 35.9%). There was also a
trend toward higher mortality among culture-positive
patients who received appropriate antibiotics (41.9%)
than culture-negative patients. These findings do not
invalidate the Surviving Sepsis Campaign’s recommenda-
tion, especially since it is impossible to accurately predict
one’s culture status at presentation. On the clinical front,
we echo the Surviving Sepsis Campaign guidelines’ advice
for cautious consideration of antimicrobial therapy using
clinician judgment and available clinical information
when cultures are unrevealing [5]. On the research front,
we propose that it is time for more in-depth studies of
culture-negative sepsis. Such investigations could come
in the form of multiplex PCR amplification techniques
for the quantification of bacteria, fungi, and viruses to
elucidate the false-negative and true-negative rates of
cultures [20,24], and interventional trials comparing algo-
rithms to escalate, continue, narrow, or cease antibiotics
coupled with a search for noninfectious etiologies when
pathogens are not detected [30].
Our study has several limitations. First, it compart-
mentalizes sepsis into two main groups based on the
identification, or lack thereof, of pathogenic microorgan-
isms, but in reality, both groups are a mixed bag of
diagnoses [31]. As discussed at length above, the
culture-negative group probably included some patients
with nonbacterial sepsis and patients without sepsis.
Nonetheless, the incidence of culture-negative sepsis in
our cohort mirrors that in multiple studies internationally
[3,10,11,16-18], and this reinforces the need to better
understand this real-world phenomenon. As for the
culture-positive group, Pseudomonas aeruginosa was the
only bacteria that independently increased mortality, a
finding that has also been seen in European ICUs [11].
Besides, bacteremia is often seen as a harbinger of bad
outcomes and thus may not be equivalent to the identi-
fication of pathogens in bodily fluids other than blood
[31,32]. This notwithstanding, our analyses suggest no
difference in mortality between bacteremic and nonbac-
teremic culture-positive sepsis. Second, because we left the
performance of cultures to the discretion of the managing
physicians, we are unable to rule out the fact that some
patients were culture-negative simply because of inap-
propriate sampling. Nonetheless, given that most cultures
were performed in an equal proportion of patients in the
culture-negative and the culture-positive groups, this
is less likely to be a significant contributing factor to
our findings. Third, as ours was a single-center study con-
ducted in a medical ICU, the details of its findings may
not be extrapolated to all ICU patients. Fourth, to deter-
mine the appropriateness of antimicrobial therapy, we did
not record the exact timing of administration while
reviewing the antibiotics given on the first day of ICU stay.
This timeline is longer than the three-hour window period
from the onset of sepsis suggested by the Surviving Sepsis
Campaign [5]. Nonetheless, we found in a previous study
that antibiotics were administered within three hours
75.0% of the time at our ICU [33]. Fifth, as our study was
observational in nature, unadjusted and hidden confoun-
ders might have influenced our results and conclusions.
To illustrate, although it is unlikely that significant dif-
ferences exist in the acute management of the culture-
negative and the culture-positive groups, especially
when microbiological results would not have been
available at presentation, it should still be acknowledged
that data on treatments such as fluid resuscitation are
lacking. Our study also has several strengths. It is the
first and largest prospective epidemiological study
dedicated to the difference between culture-negative
and culture-positive severe sepsis. We only included
microorganisms that were deemed by the managing
physicians to be pathogens as opposed to colonizers or
contaminants, with reference to the International Sepsis
Forum Consensus Conference guidelines [14]. To opti-
mize accuracy, data checks were performed by the
investigators.
Conclusions
Our study identified significant differences between
culture-negative and culture-positive severe sepsis, with
the former group having fewer comorbidities, milder
severity of illness, shorter hospitalizations, and lower ICU
mortality and hospital mortality. However, after adjusting
for all covariates, culture positivity did not independently
predict mortality.
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Key messages
• A large proportion of patients with severe sepsis
are culture-negative.
• Culture-negative patients have fewer comorbidities
and lower severity of illness than culture-positive
patients.
• Culture-negative patients have a shorter hospitali-
zation than culture-positive patients.
• Although culture-negative patients have lower ICU
mortality and hospital mortality than culture-positive
patients, culture positivity per se is not independently
associated with mortality on multivariable analysis.
• More research is required to better understand the
underlying causes of culture-negative severe sepsis.
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